Related Experiment Video
Updated: May 8, 2025

08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
16.0K
Cancer cachexia: exploring parallels with other paraneoplastic syndromes
Michael S Yule1,2,3, Amy Ireland1, Barry J A Laird1,2
1St Columba's Hospice, Boswall Road, Edinburgh, UK.
Current Opinion in Supportive and Palliative Care
|April 25, 2025
Summary
Cancer cachexia (CC) and other paraneoplastic syndromes (PNS) share molecular drivers, particularly pro-inflammatory cytokines. Understanding these overlaps can improve CC treatment strategies by exploring shared mechanisms.
Area of Science:
- Oncology
- Molecular Biology
- Physiology
Background:
- Cancer cachexia (CC) is a complex paraneoplastic syndrome (PNS) characterized by anorexia, weight loss, fatigue, and functional decline.
- PNS encompass a range of conditions associated with cancer, often sharing systemic effects.
Purpose of the Study:
- To explore the molecular drivers of cancer cachexia (CC) and other paraneoplastic syndromes (PNS).
- To identify shared molecular pathways between CC and other PNS.
- To highlight research gaps in understanding these overlapping syndromes.
Main Methods:
- Literature review of recent studies on CC and PNS.
- Analysis of molecular mediators and cytokine profiles.
- Identification of shared and distinct pathway components.
Main Results:
- Pro-inflammatory cytokines (e.g., IL-6, TNF-α) are central to CC and PNS, mediating muscle wasting, lipolysis, and pyrexia.
- Cytokine profiles vary by cancer type, suggesting complex interplay rather than single-cytokine effects.
- Mediators like PTHrP and VEGF link other PNS conditions to cachexia, indicating shared roles.
Conclusions:
- Significant overlap exists between CC and other PNS at the molecular level.
- Investigating these shared mechanisms is crucial for advancing CC treatment strategies.
- Examining related conditions like eating disorders, bariatric surgery, and sepsis may offer further insights.
Related Concept Videos
Cancer
47.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.0K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Cancer Survival Analysis
291
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
291
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

